AMANDA HAYS: Open Payments
NPI 1659870376 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 43 payments from 14 companies in 2025. Trend: 2023 $1,289 · 2024 $1,740 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $399 |
| Sumitomo Pharma America, Inc. | 7 | $177 |
| PFIZER INC. | 7 | $135 |
| UROGEN PHARMA, INC. | 6 | $111 |
| Dendreon Pharmaceuticals LLC | 3 | $85 |
| Endo USA, Inc. | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $31 |
| IMMUNITYBIO, INC. | 1 | $28 |
| 180 Medical, Inc. | 1 | $27 |
Products named: ERLEADA, GEMTESA, PROVENGE, ORGOVYX, TALZENNA, AVEED, XTANDI, ANKTIVA.
Industry payments across AL — which companies pay providers there.
